Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Greaves, Ronda / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter


IMPACT FACTOR 2018: 3.638

CiteScore 2018: 2.44

SCImago Journal Rank (SJR) 2018: 1.191
Source Normalized Impact per Paper (SNIP) 2018: 1.205

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 48, Issue 6

Issues

Diagnostic performance of anti-citrullinated peptide antibodies for the diagnosis of rheumatoid arthritis: the relevance of likelihood ratios

Donatello Pietrapertosa / Barbara Tolusso / Elisa Gremese / Maria Concetta Papalia / Silvia Laura Bosello / Giusy Peluso / Luca Petricca / Alessandro Michelutti / Francesca Faustini / Anna Laura Fedele / Gianfranco Ferraccioli
Published Online: 2010-03-19 | DOI: https://doi.org/10.1515/CCLM.2010.152

Abstract

Background: The goal of our study was to evaluate the diagnostic performance of the anti-cyclic citrullinated peptide 2 (anti-CCP2) assay in patients with autoimmune and inflammatory disorders.

Methods: We tested the specificity and sensitivity of anti-CCP2 antibodies measured by ELISA in 787 patients with rheumatoid arthritis (RA), 1024 patients with other autoimmune/inflammatory rheumatic disease and 401 subjects without autoimmune rheumatic disease. The optimal cut-off value was defined as the value with the highest diagnostic accuracy (receiver operating characteristic curve analysis). Interval-specific likelihood ratios (LRs) were calculated for each range bounded by defined anti-CCP2 values.

Results: To distinguish between patients with RA and controls, the cut-off value with the highest diagnostic accuracy for anti-CCP2 was 2.8 U/mL. Comparing the optimal cut-off value for anti-CCP2 to that recommended by the manufacturer (5.0 U/mL), an increase in prevalence between the proportions of test-positive patients was found for RA, undifferentiated connective tissue disease and undifferentiated arthritis. Evaluating interval-specific LRs for the selected ranges bound by two anti-CCP2 values, in RA and diseased controls, the LRs were 0.40 for values <5.0 U/mL, 6.66 for 5.0–15.0 U/mL, 27.01 for 15.1–30.0 U/mL and 28.89 for >30.0 U/mL.

Conclusions: The cut-off value of 2.8 U/mL for anti-CCP2 has the highest diagnostic accuracy. A value of anti-CCP2 >15 U/mL is associated with an increase in the likelihood of RA disease.

Clin Chem Lab Med 2010;48:829–34.

Keywords: anti-CCP2; cut-off; diagnostic accuracy; likelihood ratios; rheumatoid arthritis

About the article

Corresponding author: Gianfranco Ferraccioli, MD, Professor of Rheumatology, School of Medicine, Catholic University of the Sacred Heart, Via Moscati 31, 00168, Rome, Italy


Received: 2009-11-24

Accepted: 2010-01-17

Published Online: 2010-03-19

Published in Print: 2010-06-01


Citation Information: Clinical Chemistry and Laboratory Medicine, Volume 48, Issue 6, Pages 829–834, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2010.152.

Export Citation

©2010 by Walter de Gruyter Berlin New York.Get Permission

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Xin Wu, Xiaobao Sheng, Rong Sheng, Hongjuan Lu, and Huji Xu
Frontiers of Medicine, 2019, Volume 13, Number 4, Page 411
[2]
SARA CATERBI, ONELIA BISTONI, ALESSIA ALUNNO, ELENA BARTOLONI, and ROBERTO GERLI
The Journal of Rheumatology, 2015, Volume 42, Number 6, Page 1063
[3]
Judith Payet, Claire Goulvestre, Lisa Bialé, Jérôme Avouac, Julien Wipff, Chantal Job-Deslandre, Frédéric Batteux, Maxime Dougados, André Kahan, and Yannick Allanore
The Journal of Rheumatology, 2014, Volume 41, Number 12, Page 2395
[4]
HONGYAN WEN, H. RALPH SCHUMACHER, SALLY W. PULLMAN-MOOAR, and EUGENE EINHORN
The Journal of Rheumatology, 2011, Volume 38, Number 8, Page 1806
[5]
Aase Haj Hensvold, Thomas Frisell, Patrik K E Magnusson, Rikard Holmdahl, Johan Askling, and Anca Irinel Catrina
Annals of the Rheumatic Diseases, 2017, Volume 76, Number 1, Page 119
[6]
Salvatore Corrao, Christiano Argano, Luigi Calvo, and Giovanni Pistone
Internal and Emergency Medicine, 2015, Volume 10, Number 3, Page 271
[7]
Jamileh Moghimi, Raheb Ghorbani, Farnaz Hasani, and Mehrdad Sheikhvatan
Rheumatology International, 2013, Volume 33, Number 3, Page 601
[8]
Gianfranco Ferraccioli and Elisa Gremese
Internal and Emergency Medicine, 2011, Volume 6, Number S1, Page 11
[9]
Salvatore Corrao, Luigi Calvo, and Giuseppe Licata
European Journal of Internal Medicine, 2011, Volume 22, Number 3, Page 217

Comments (0)

Please log in or register to comment.
Log in